MedPath

Neuropeptide Y

Generic Name
Neuropeptide Y
Brand Names
-
Drug Type
Biotech
Chemical Formula
-
CAS Number
82785-45-3
Unique Ingredient Identifier
BY7U39XXK0
Background

Neuropeptide Y is under investigation for the basic science of Type 2 Diabetes Mellitus.

Associated Conditions
-
Associated Therapies
-
epilepsy.com
·

Summary of Anti-Seizure Medications

Choosing anti-seizure medications (ASMs) involves considering side effects, seizure types, cost, and physician experience. No single ASM is universally effective; selection depends on individual patient needs. ASMs are categorized as narrow or broad-spectrum, with some seizures resistant to treatment. Generic drugs may differ in effectiveness from brand names. Side effects vary, including weight changes, cognitive issues, and organ impacts. AEDs suppress seizures but do not cure epilepsy. Detailed drug profiles highlight mechanisms, side effects, and dosing strategies.
nature.com
·

Clinical-exome sequencing unveils the genetic landscape of polycystic ovarian syndrome

The study investigates genetic variations in PCOS among Bengali women from West Bengal, India, highlighting differences between lean and obese PCOS groups. It identifies key genetic mutations and their implications for precision medicine. The research underscores the importance of genetic mapping stratified by BMI and suggests future studies with larger sample sizes for validation.

An Overview of Epigenetics in Obesity: The Role of Lifestyle and Environmental Factors

Obesity's rise is linked to genetics, lifestyle, and environmental factors, with epigenetics playing a key role in energy metabolism. Modern lifestyles, including high-calorie diets and sedentary behavior, contribute significantly. Epigenetic changes, reversible and influenced by environment and lifestyle, offer therapeutic targets. Research highlights the importance of understanding these mechanisms for obesity management and prevention.
© Copyright 2025. All Rights Reserved by MedPath